For Quick Alerts
For Daily Alerts

Domestic pharma shares surge on Novartis ruling

Domestic pharma shares surge on Novartis ruling
Shares in domestic pharma companies surged after the Supreme Court rejected a cancer patent for multinational company Novartis.

Monday's ruling comes as a setback to many renowned global pharma companies that are looking at India to boost sales.

Commenting on the ruling, DG Shah, Indian Pharmaceutical Alliance (IPA) secretary said, "This is a landmark judgement that will serve to set at rest the controversy that was raised regarding the scope of section 3(d) in the Patents Act, which is a crucial safeguard against the extension of patent monopolies of known drugs and the consequent delay in the availability of affordable generic versions."

Shares of the Sun Pharma surged more than 4% to Rs 846, Divis Labs gained 4.12%, Glenmark rose 3.87% and Aurobindo Pharma gained 2.80% on BSE at 2.30 pm IST.

Read more about: pharma
Company Search
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more